Back to Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 3 » default

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy


Archive: Volume 3, 2010

Curcumin improves prostanoid ratio in diabetic mesenteric arteries associated with cyclooxygenase-2 and NF-κB suppression

Sirada Rungseesantivanon, Naris Thengchaisri, Preecha Ruangvejvorachai, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:421-429

Published Date: 6 December 2010

Anthropometric cutoff values for detecting metabolic abnormalities in Jordanian adults

Yousef S Khader, Anwar Batieha, Hashim Jaddou, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:395-402

Published Date: 18 November 2010

Lifestyle modification in the management of the metabolic syndrome: achievements and challenges

Riccardo Dalle Grave, Simona Calugi, Elena Centis, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:373-385

Published Date: 2 November 2010

Imaging body composition in obesity and weight loss: challenges and opportunities

Heidi J Silver, E Brian Welch, Malcolm J Avison, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:337-347

Published Date: 28 September 2010

Saxagliptin for type 2 diabetes

Antonio R Chacra, MD

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:325-335

Published Date: 22 September 2010

Anorexia nervosa depends on adrenal sympathetic hyperactivity: opposite neuroautonomic profile of hyperinsulinism syndrome

Fuad Lechin, Bertha van der Dijs, Betty Pardey-Maldonado, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:311-317

Published Date: 9 September 2010

Beta-cell function is associated with metabolic syndrome in Mexican subjects

Blanca G Baez-Duarte, Maria Del Carmen Sanchez-Guillen, Ricardo Perez-Fuentes, et al.

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:301-309

Published Date: 30 August 2010

Optimizing weight control in diabetes: antidiabetic drug selection

S Kalra, B Kalra, AG Unnikrishnan, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:297-299

Published Date: 24 August 2010

The economic impact of obesity in the United States

Ross A Hammond, Ruth Levine

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:285-295

Published Date: 30 August 2010

Aerobic training increases skin perfusion by a nitric oxide mechanism in type 2 diabetes

Sheri R Colberg, Laura C Hill, Henri K Parson, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:275-280

Published Date: 4 August 2010

Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes

Joshua J Neumiller, Travis E Sonnett, Lindy D Wood, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:215-226

Published Date: 14 July 2010

Prolylcarboxypeptidase (PRCP) as a new target for obesity treatment

B Shariat-Madar, D Kolte, A Verlangieri, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:67-78

Published Date: 19 April 2010

Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes

Henri K Parson, Meredith A Bundy, Charlotte B Dublin, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:19-26

Published Date: 25 January 2010

A molecular mechanism for diacylglycerol-mediated promotion of negative caloric balance

Hidekatsu Yanai, Yoshiharu Tomono, Kumie Ito, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:1-6

Published Date: 18 December 2009